Use of Sodium–Glucose Cotransporter 2 (SGLT-2) Inhibitors Beyond Diabetes: On the Verge of a Paradigm Shift?. Rhythmos [Internet]. 2020 Jan. 28 [cited 2025 May 3];15(1):1-5. Available from: https://www.rhythmos.gr/index.php/Rhythmos/article/view/473